Intensive BP Targeting Significantly Reduces Major Cardiovascular Events in Type 2 Diabetes
The BROAD trial provides strong evidence that intensive management of systolic blood pressure to a target of <120 mmHg significantly reduces the risk of major cardiovascular events in patients with Type 2 diabetes compared to the standard treatment target of <140 mmHg.
Re-Analysis of the STRESS Trial shows benefits of Prophylactic Steroids in Infant Heart Surgery
The STRESS trial initially showed no significant difference between infants receiving methylprednisolone and placebo in the primary analysis, but secondary unadjusted analyses suggested potential benefits. Researchers re-analyzed the trial to further assess the potential benefits or harms of methylprednisolone use.
Ablation vs Antiarrhythmic drugs for Ventricular Tachycardia? Insights from AHA Scientific Session 2024
The VANISH 2 study, presented at the AHA Scientific Sessions 2024, is the first to directly compare catheter ablation and antiarrhythmic drug therapy as initial treatments for patients with prior myocardial infarction, an ICD, and sustained monomorphic VT.
About the Medical Education Network
About Us
The Medical Education Network is an independent, free-for-use resource for healthcare practitioners in sub-Saharan Africa.
We provide a range of quality clinical information sourced from peer-reviewed journals and original articles to facilitate continued medical education and knowledge sharing.
If you would like to be involved with our programs or contribute to our site, please contact us
Our Policies
Your information and the quality of our content are important to us.
Our policies are listed below. If you have any concerns, please contact us
Privacy Policy
Acceptable Use Policy
Cookies and how we use them
General Information relating to your data
Fact-Checking and General Content Disclaimers
Contact Us
Sign-up for our Newsletters
General Site Queries
Advertising & Sponsorship Queries
Contributors & Authors
Follow us on our Social Media platforms
